Action Radiotherapy is supported and run by some of the most experienced UK and international radiotherapy specialists.
Professor Pat Price
She took up a research position under a Cancer Research Campaign Clinical Fellowship at the Institute of Cancer Research, London, and won the Cambridge University prize for best laboratory based MD. She then went on to work at the Hammersmith Hospital, London as a Senior Lecturer.
While at the Hammersmith Professor Price developed a research interest in molecular imaging for oncology and set up and headed the Medical Research Council and Cancer Research Campaign Positron Emission Tomography (PET) Oncology Programmes. She moved to Manchester in September 2000 to take up the Ralston Paterson Chair in Radiation Oncology and set up the new Wolfson Molecular Imaging Centre at the Christie Hospital. She is now Visiting Professor at Imperial College London.
Professor Malcolm Mason
Professor Malcolm Mason is a clinician who specialises in the management of urological cancers, in which capacity he is the Chairman of the UK National Cancer Research Institute’s Prostate Cancer Clinical Studies Group. He is an experienced Clinical Researcher, has been the Chief Investigator for a number of Medical Research Council trials, and he has over 250 publications in his field. For the UICC (International Union Against Cancer) he Chairs the UK TNM Committee, and sits on the Core Group and the Prognostic Factors Task Group. Since 2003 he has been the Director of the Wales Cancer Bank, the UK’s first population-based tumour and blood sample collection, which to date has recruited over 3,900 patients. He also has laboratory research interests in prostate cancer, focused on immunology and on cancer metastasis.
Ms Tanya Levine
Judith Potts is a former actress and current acting, voice and presentation coach. She writes speeches and presentations – often directing the latter.
She writes a (pro bono) Health Column for the Telegraph – principally about cancer and its attendant issues. She is the Founder of Esme’s Umbrella (www.charlesbonnetsyndrome.uk) – the Awareness Campaign for the little-known frightening, hallucinatory condition called Charles Bonnet Syndrome. The Campaign seeks to raise awareness amongst the medical profession and the community, to prevent those who develop the condition from suffering in silence with the word ‘dementia’ hanging above them. CBS is not a form of dementia but caused by deteriorating vision, which allows the brain to ‘fill in the blanks’ with images – which range from disturbing to terrifying.
She was diagnosed with breast cancer in 2008 for which she received a course of radiotherapy.
Dr Christy Goldsmith
Dr Christy Goldsmith is a Clinical Oncologist specialising in an advanced radiotherapy technique called Stereotactic Body Radiotherapy (SBRT). She is a Committee Member on the SABR Consortium UK, a Consortium which has been active in advocating for access for patients to SBRT treatment, as well as developing treatment guidelines, and furthering UK SBRT research.
Dr Goldsmith has presented Internationally at Radiotherapy meetings (ASTRO/ESTRO/RSS) on outcomes of UK SBRT. She has also ran the British 10k London to fundraise for Action Radiotherapy.
Mr David Ardron
David Ardron’s parents were both treated with radiotherapy and he feels passionately about the need for further investment in radiotherapy research. His mother is still alive almost 20 years on from major surgery and radiotherapy treatment for breast cancer in 1994.
“We can now monitor images of patients as they receive radiotherapy in a way which was impossible 10 years ago, when my father was having his treatment for lung cancer,” says 58-year-old David, who lives in South Yorkshire.
Nowadays David is very much part of the medical world, travelling across the UK, and occasionally the globe, championing the cause of patients treated for cancer and the quest to find a cure. He was chair of the NCRI Consumer Liaison Group for four years until 2012, and is chair of a consumer research panel in the North Trent Cancer Research Network. The patients and carers he works with, all contribute to health research to ensure that any research is focussed on outcomes which are important to patients and their families. The panel in Sheffield held a conference in 2012 which invited members of the public to listen to radiotherapy researchers from Sheffield, Newcastle, London and Manchester speaking about their work in the field.
In 2011, as part of the Year of Radiotherapy, David wrote an article for The Times about the benefits of modern radiotherapy and the work of Action Radiotherapy.
Mr Stephen Adolphus
Stephen Adolphus practices Maritime law. He was an early member of Action Radiotherapy and was involved with the charity in the early stages. In addition to helping with fund raising he provided legal advice to the charity.
Stephen takes an interest in all forms of cancer treatments but takes a particular interest in the new developments in focused radiotherapy. He has family members who have benefited from a course of radiotherapy. He recognises the huge breakthroughs that have been made in this area of modern non-invasive radiotherapy.
Professor Philip Mayles